Clearmind Medicine Inc. (CMND)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
1.36
-0.01 (-0.73%)
At close: Jan 30, 2025, 3:59 PM
1.35
-0.74%
After-hours Jan 30, 2025, 06:26 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 26.70K | 56.34K | 113.38K | 2.57K | n/a | n/a | n/a | n/a |
Gross Profit | -26.70K | -56.34K | -113.38K | -2.57K | n/a | n/a | n/a | n/a |
Operating Income | -6.30M | -8.74M | -8.53M | -3.45M | -233.22K | -105.28K | -254.53K | -6.67K |
Interest Income | 271.22K | 57.97K | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -4.88M | -11.93M | -9.37M | -3.90M | -233.22K | -105.28K | -194.53K | -6.67K |
Net Income | -5.25M | -11.96M | -9.41M | -4.12M | -233.22K | -105.28K | -194.53K | -6.67K |
Selling & General & Admin | 4.35M | 6.60M | 5.43M | 3.03M | 233.22K | 105.28K | 254.53K | 6.67K |
Research & Development | 1.38M | 2.14M | 2.98M | 646.49K | n/a | n/a | n/a | n/a |
Other Expenses | n/a | n/a | 113.38K | n/a | n/a | n/a | 60.00K | n/a |
Operating Expenses | 5.72M | 8.74M | 8.53M | 3.68M | 233.22K | 105.28K | 254.53K | 6.67K |
Interest Expense | 36.16K | n/a | 19.68K | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 2.57M | 8.74M | 8.53M | 3.68M | 233.22K | 105.28K | 254.53K | 6.67K |
Income Tax | 377.97K | 24.09K | 40.75K | 223.22K | -385.99K | -171.86K | -60.00K | n/a |
Shares Outstanding (Basic) | 4.27M | 2.02M | 433.34K | 309.11K | 181.30K | 123.33K | 107.79K | 122.22K |
Shares Outstanding (Diluted) | 4.27M | 2.02M | 433.34K | 309.11K | 181.30K | 123.33K | 107.79K | 122.22K |
EPS (Basic) | -1.7 | -42.58 | -168.61 | -95.67 | -9.56 | -6.42 | -14.02 | -0.42 |
EPS (Diluted) | -1.7 | -42.58 | -168.61 | -95.67 | -9.56 | -6.42 | -14.02 | -0.42 |
EBITDA | -5.85M | -8.71M | -8.49M | -3.67M | -233.22K | n/a | -56.27K | -6.67K |
Depreciation & Amortization | 51.07K | 30.69K | 113.38K | 2.57K | 179.69K | 86.00K | 161.14K | n/a |